Medical News

RSS

Study reports protective shield fluoride on teeth is 100 times thinner

In a study that the authors describe as lending credence to the idiom, "by the skin of your teeth," scientists are reporting that the protective shield fluoride forms on teeth is up to 100 times thinner than previously believed.

16 Dec 2010

Perirhinal cortex critical for forming unconscious conceptual memories

A small area deep in the brain called the perirhinal cortex is critical for forming unconscious conceptual memories, researchers at the UC Davis Center for Mind and Brain have found.

16 Dec 2010

Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target

Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.

16 Dec 2010

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, announces the award of a grant from the ANR (the French state Research National Agency) and a label award from both "Clusters of excellence", Medicen Paris Region and Atlanpole, for two new applications of its mucoadhesive Lauriad™ technology. These projects are dedicated to the development of new biological products based on the Lauriad™ technology allowing mucous penetration of a biologically active compound.

16 Dec 2010

AMA commends President Obama for commitment to one-year delay of Medicare cut into law

"Today, President Obama signed into law a one-year delay of the looming Medicare physician payment cut that would have hurt seniors' health care. The AMA commends President Obama and bipartisan leaders in the Senate and House for their commitment to a year-long delay of the 25 percent cut. The AMA strongly advocated for this one-year delay to create a stable environment for seniors and their physicians.

16 Dec 2010

Fabric softener sheets repel fungus gnat adults under laboratory conditions

For years, gardeners have claimed that putting Bounce- fabric softener sheets in their pockets is an effective way to repel pests like mosquitoes and gnats.

16 Dec 2010

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.

16 Dec 2010

IDS recieves grant for two CLTM systems

Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that it has received deposits for two CTLM systems from its distributor Mukesh Jain of Jainsons Pty Ltd for India and Indonesia.

16 Dec 2010

BELLUS Health, Celtic Therapeutics initiate KIACTA global confirmatory phase III clinical study for AA amyloidosis

BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.

16 Dec 2010

IPS examines NGOs' call to reform World Bank's funding for poorest countries

"With the World Bank expected to announce a new funding package for the world's poorest countries Wednesday, NGOs are making a last-minute appeal to donor countries to use their leverage to compel reforms at the institution," Inter Press Service reports in an article examining the changes being requested and considered.

16 Dec 2010

Study: People who believe in justice believe that tragedy gives the victim's life more meaning

Seeing bad things happen to other people is scary. One way to respond to this is to blame the victim-to look for some reason why it happened to them. But there's another common response, according to a new study published in Psychological Science, a journal of the Association for Psychological Science. The researchers found that people who believe in justice in the world also believe that a tragedy gives the victim's life more meaning.

16 Dec 2010

ADA supports FDA panel's recommendation for continuing review of existing, new scientific information

The American Dental Association today praised a Food and Drug Administration advisory panel's finding that the FDA acted appropriately when it ruled last year that dental amalgam is a safe and effective treatment option for the general population.

16 Dec 2010

EBRI report: Young people, minorities, and low-wage workers more likely to find financial incentives extremely useful

The overall percentage of people who think getting a financial incentive would be extremely or very useful for choosing a more effective treatment decreased from 61 percent in 2009 to 55 percent in 2010, according to new report released today by the nonpartisan Employee Benefit Research Institute (EBRI).

16 Dec 2010

New study records show dementia residents seek hospice benefit

A new study of nursing home records shows more residents with dementia are seeking a hospice benefit and using it longer. The study also estimates that 40 percent of nursing home residents die with some degree of dementia.

16 Dec 2010

Adimab initiates new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences

Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.

16 Dec 2010

Almac recognised with 'News Flow of the Year' award

The Almac Group, one of the world's leading contract drug development and manufacturing organisations, was presented with the "News Flow of the Year" accolade at the 2010 Genesis Awards annual Gala dinner in London last week, following the company being shortlisted as a finalist in the category nominations. Now into its tenth year, Genesis is established as a leading life science networking conference.

16 Dec 2010

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania today report the discovery of a set of single-letter variations in the sequence of the human genome that impact individual baseline levels of prostate specific antigen, or PSA.

16 Dec 2010

Generex's buccal drug delivery platform technologies receive new patent

Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT) announced today that it has received a new patent for its buccal drug delivery platform technologies. The Canadian Intellectual Property Office has granted to Generex Canadian Patent No. 2,354,148, a patent titled Aerosol Formulations for Buccal and Pulmonary Application.

16 Dec 2010

CEL-SCI receives Ukraine government approval for Multikine Phase III clinical trial in head and neck cancer

CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.

16 Dec 2010

Combination therapy improves survival rates in patients with advanced non-small cell lung cancer

A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.

16 Dec 2010

Medical News

Study reports protective shield fluoride on teeth is 100 times thinner

Perirhinal cortex critical for forming unconscious conceptual memories

Zenobia, Lundbeck enter research collaboration for LRRK2 Parkinson's disease target

BioAlliance wins grant and award for new applications of mucoadhesive Lauriad technology

AMA commends President Obama for commitment to one-year delay of Medicare cut into law

Fabric softener sheets repel fungus gnat adults under laboratory conditions

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

IDS recieves grant for two CLTM systems

BELLUS Health, Celtic Therapeutics initiate KIACTA global confirmatory phase III clinical study for AA amyloidosis

IPS examines NGOs' call to reform World Bank's funding for poorest countries

Study: People who believe in justice believe that tragedy gives the victim's life more meaning

ADA supports FDA panel's recommendation for continuing review of existing, new scientific information

EBRI report: Young people, minorities, and low-wage workers more likely to find financial incentives extremely useful

New study records show dementia residents seek hospice benefit

Adimab initiates new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences

Almac recognised with 'News Flow of the Year' award

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

Generex's buccal drug delivery platform technologies receive new patent

CEL-SCI receives Ukraine government approval for Multikine Phase III clinical trial in head and neck cancer

Combination therapy improves survival rates in patients with advanced non-small cell lung cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News